- Title
-
Short-Term TERT Inhibition Impairs Cellular Proliferation via a Telomere Length-Independent Mechanism and Can Be Exploited as a Potential Anticancer Approach
- Authors
- Amin, A., Morello, M., Petrara, M.R., Rizzo, B., Argenton, F., De Rossi, A., Giunco, S.
- Source
- Full text @ Cancers
Telomerase inhibition altered RELA proto-oncogene NF-kB subunit (p65) nuclear levels. ( |
Telomerase reverse transcriptase (TERT) inhibition downregulated MYC proto-oncogene bHLH transcription factor (MYC) levels. ( |
Ectopic expression of TERT or TERT-HA increased transcription of NF-κB target genes. U2OS cells were transfected with pBABE-hTERT, pBABE-hTERT-HA, or pBABE (control) vectors. Forty-eight h after transfection, RNA was harvested and mRNA levels for the genes indicated were determined by quantitative RT-PCR. Data represent the mean and SD (bar) from three separate experiments. A significant difference between values in pBABE-hTERT or pBABE-hTERT-HA transfected cells vs. control pBABE-transfected cells is shown: * |
p65 inhibition recapitulated the effects of TERT inhibition on MYC and the cell cycle. ( |
Telomerase inhibition enhanced the expression and nuclear localization of cyclin-dependent kinase inhibitor 1A (CDKN1A, P21). ( |
BIBR treatment downregulated the expression of zebrafish |
Combined treatment with BIBR and fludarabine (FLU) or cyclophosphamide (CY) inhibited the growth of EBV-immortalized and fully transformed B cells xenografted in zebrafish. 4134/Late ( |